Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
3.
Mucosal Immunol ; 7(5): 1255-65, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24621993

ABSTRACT

The incidence and severity of Crohn's disease (CD) are increased in female patients. Using SAMP1/YitFc (SAMP) mice, a spontaneous model of chronic intestinal inflammation that displays histologic and pathogenic similarities to human CD, we investigated the potential mechanism(s) contributing to sex differences observed in CD. Similar to gender differences observed in CD patients, SAMP female (SAMP-F) mice displayed an earlier onset and more severe ileitis compared with SAMP male (SAMP-M) mice. Furthermore, T-regulatory cells (Tregs) from gut-associated lymphoid tissue (GALT) of SAMP-F mice were reduced in frequency and impaired in their in vitro and in vivo suppressive functions compared with that of SAMP-M mice. Given the interaction between sex hormones and Treg function, we investigated the possible role of estrogen (E2) in SAMP ileitis. SAMP-M mice responded to exogenous E2 administration by expanding Treg frequency and reducing ileal inflammation, whereas SAMP-F mice were resistant. Conventional T cells and Tregs responded differentially to estrogen signaling, leading to distinct immunoprotective effects mediated by distinct estrogen receptor (ER) isoforms. These mechanisms were impaired in T cells from SAMP-F mice. Thus, hormone signaling influences the expansion and function of GALT Tregs in an ER-dependent manner and contributes to gender-based differences in experimental CD.


Subject(s)
Crohn Disease/immunology , Crohn Disease/physiopathology , Ileitis/physiopathology , Animals , Crohn Disease/drug therapy , Disease Models, Animal , Estrogens/pharmacology , Female , Flow Cytometry , Ileitis/drug therapy , Male , Mice , Sex Factors , T-Lymphocytes, Regulatory/drug effects
4.
J Leukoc Biol ; 86(2): 261-71, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19401392

ABSTRACT

TLRs are a family of molecules that function as sensors for the detection of pathogens. TLR-9, expressed on B cells and pDCs, recognizes CpG motifs of unmethylated bacterial DNA and plays a role in the development of autoimmunity. The present study was designed to investigate the effects of IFN-alpha in combination with CpG ODN on the activation of CD27(-) naïve B cells and on Ig production. We provide evidence that CpG ODN not only induces a total and T-dependent, specific IgM response by naïve B cells but also their phenotypic differentiation in plasma cells, as demonstrated by the up-regulation of CD38 expression. We found that TLR-9 stimulation with CpG ODN induces IL-1beta, TNF-alpha, IL-10, and IL-6 production. Interestingly, we also found that CpG ODN induces naïve B cell maturation into memory cells, as demonstrated by the induction of CD27, AID mRNA expression, and IgG production. More importantly, our results demonstrate that IFN-alpha amplifies the inductive effect of CpG ODN on naïve B activation and on Ig production through a mechanism involving TLR-9/MyD88-dependent signaling. Moreover, we found that IFN-alpha enhances the frequency of CpG ODN-induced memory B cells. Our results may contribute to clarify the events promoting IFN-alpha-induced amplification of naïve B cell activation via TLR-9 for a better understanding of the pathogenesis of autoimmune disorders and may guide treatments targeting this pathway within B cells.


Subject(s)
Antibody Formation/immunology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Interferon-alpha/metabolism , Lymphocyte Activation/immunology , Toll-Like Receptor 9/immunology , ADP-ribosyl Cyclase 1/metabolism , Antibody Formation/drug effects , B-Lymphocytes/drug effects , Cell Differentiation/drug effects , Cell Differentiation/immunology , Cells, Cultured , Cytidine Deaminase/genetics , Cytidine Deaminase/metabolism , Cytokines/metabolism , Humans , Immunoglobulin G/metabolism , Immunoglobulins/metabolism , Immunologic Memory/drug effects , Immunologic Memory/immunology , Interferon-alpha/pharmacology , Lymphocyte Activation/drug effects , Membrane Glycoproteins/metabolism , Oligodeoxyribonucleotides/pharmacology , Phenotype , Plasma Cells/drug effects , Plasma Cells/immunology , Plasma Cells/metabolism , Toll-Like Receptor 9/agonists , Tumor Necrosis Factor Receptor Superfamily, Member 7/genetics , Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism
5.
Transplant Proc ; 39(6): 1877-8, 2007.
Article in English | MEDLINE | ID: mdl-17692639

ABSTRACT

We reviewed the literature reports and our personal experience on partial portal vein arterialization (PPVA) to prevent and treat acute liver failure (ALF) following major hepatobiliary surgery or another etiology. Experimental studies in rats have assessed the efficacy of PPVA in treatment of ALF induced by extended resections in normal or fatty livers or in toxic carbon-tetrachloride damage. The treated groups showed greater survival and faster recovery of liver function. Among 11 clinical cases reported in the literature, PPVA was performed in four cases to prevent and in seven cases to treat ALF. Eight patients survived, showing rapid recovery of liver function and resolution of the clinical condition. This relatively simple procedure has shown itself able to promote liver regeneration. The PPVA procedure has shown itself to be safe and simple as well as to offer a promising approach to the failing liver.


Subject(s)
Hepatic Artery , Liver Circulation , Liver Regeneration/physiology , Liver Transplantation/methods , Portal Vein/surgery , Humans , Liver Failure/prevention & control , Liver Failure/therapy , Postoperative Complications/prevention & control
6.
Transplant Proc ; 38(10): 3249-50, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17175238

ABSTRACT

AIM: We sought to determine whether an additional supply of oxygenated blood achieved by partial portal vein arterialization (PPVA) was protective on normal or fatty liver (FL) in rats with acute liver failure (ALF) induced by hepatectomy. METHODS: Sprague-Dawley rats with normal or FL were segregated either to receive or not to undergo PPVA after hepatectomy. FL was induced by feeding a choline-deficient diet (5 days). PPVA was performed by anactamasing the left renal artery to the splenic vein with a stent following a left nephrectomy and splenectomy; the control rats underwent left nephrectomy and splenectomy only. Liver injury was evaluated by the serum alanine aminotransferase (ALT) level. The animals were sacrificed at 24 hours, 48 hours, and 7 days to collect blood and liver tissue samples for biochemical analysis. The 7-day survival was assessed in separate experimental groups. RESULTS: PPVA significantly increased Po2 and oxygen saturation in the portal blood compared to non PPVA rats. PPVA significantly improved the 7-day survival compared with controls in both groups: hepatectomy of normal liver (90% vs 30%) and hepatectomy of FL (75% vs 25%). Serum ALT levels were slightly lower in the PPVA groups compared with the non-PPVA groups without a significant difference. Prothrombin activity decreased soon after hepatectomy in the normal and the FL liver groups but recovered rapidly thereafter without differences between the PPVA and non-PPVA treated animals. CONCLUSION: An additional supply of arterial oxygenated blood through a PPVA promotes rapid resolution of ALF after partial hepatectomy in rats with normal or fatty livers, significantly improving 7-day survivals compared to hepatectomy controls.


Subject(s)
Fatty Liver/surgery , Hepatectomy , Hepatic Artery/surgery , Liver Failure, Acute/prevention & control , Portal Vein/surgery , Anastomosis, Surgical , Animals , Choline Deficiency , Disease Models, Animal , Oxygen/blood , Oxygen Consumption , Portal System/physiology , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...